S AMP L E INF ORMAT ION

Sample Name: Standard Acquired By: Irvin

Sample Type: Standard Sample Set Name: Allergex 183 194 RT
Vial: 2:A,1 Acq. Method Set: Allergex Tablets Assay MS 3
Injection #: 1, 6, 2, 4, 5, 3, 7 Processing Method: Allergex Tablets PM2
Injection Volume: 10.00 ul Channel Name: 2998 Ch1 265nm@4.8nm
Run Time: 5.0 Minutes Proc. Chnl. Descr.: 2998 Ch1 265nm@4.8nm

Date Acquired: 9/29/2020 2:13:31 PM CAT, 9/29/2020 2:19:04 PM CAT, 9/29/2020 2:24:38 PM CAT, 9/29/2020
Date Processed: 10/1/2020 2:20:14 PM CAT, 10/1/2020 2:20:48 PM CAT, 10/1/2020 2:20:49 PM CAT, 10/1/2020

1.20
Chlopheniramine Maleate

1.00

0.80
AU

0.60

0.40

0.20
unk

0.00

0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00 4.50 5.00
Minutes
SampleName: Standard; Vial: 2:A,1; Injection: 1; Channel: 2998 Ch1 265nm@4.8nm; Date Acquired: 9/29/2020
2:13:31 PM CAT
SampleName: Standard; Vial: 2:A,1; Injection: 2; Channel: 2998 Ch1 265nm@4.8nm; Date Acquired: 9/29/2020
2:19:04 PM CAT
SampleName: Standard; Vial: 2:A,1; Injection: 3; Channel: 2998 Ch1 265nm@4.8nm; Date Acquired: 9/29/2020
2:24:38 PM CAT
SampleName: Standard; Vial: 2:A,1; Injection: 4; Channel: 2998 Ch1 265nm@4.8nm; Date Acquired: 9/29/2020
2:30:18 PM CAT
SampleName: Standard; Vial: 2:A,1; Injection: 5; Channel: 2998 Ch1 265nm@4.8nm; Date Acquired: 9/29/2020
2:35:51 PM CAT
SampleName: Standard; Vial: 2:A,1; Injection: 6; Channel: 2998 Ch1 265nm@4.8nm; Date Acquired: 9/29/2020
2:41:30 PM CAT
SampleName: Standard; Vial: 2:A,1; Injection: 7; Channel: 2998 Ch1 265nm@4.8nm; Date Acquired: 9/29/2020
2:47:10 PM CAT
 System Suitability Summary Results
Name: Chlopheniramine Maleate
USP USP
Sample Name Vial Inj Channel Name RT Area
Resolution Tailing
1 Standard 2:A,1 1 2998 Ch1 265nm@4.8nm Chlopheniramine Maleate 1.328 3196347 1.882494 1.231498
2 Standard 2:A,1 2 2998 Ch1 265nm@4.8nm Chlopheniramine Maleate 1.328 3188681 1.863121 1.233139
3 Standard 2:A,1 3 2998 Ch1 265nm@4.8nm Chlopheniramine Maleate 1.328 3183369 1.851538 1.233745
4 Standard 2:A,1 4 2998 Ch1 265nm@4.8nm Chlopheniramine Maleate 1.328 3180908 1.867962 1.232835
5 Standard 2:A,1 5 2998 Ch1 265nm@4.8nm Chlopheniramine Maleate 1.327 3176261 1.841173 1.233995
6 Standard 2:A,1 6 2998 Ch1 265nm@4.8nm Chlopheniramine Maleate 1.326 3166803 1.860297 1.237246
7 Standard 2:A,1 7 2998 Ch1 265nm@4.8nm Chlopheniramine Maleate 1.325 3167227 1.855989 1.239561
Mean 1.327 3179942.344 1.860 1.235
Std. Dev. 0.001 10847.625 0.013 0.003
% RSD 0.1 0.3 0.7 0.2
System Suitability Summary Results
Name: unk
USP USP
Sample Name Vial Inj Channel Name RT Area
Resolution Tailing
1 Standard 2:A,1 1 2998 Ch1 265nm@4.8nm unk 0.943 316150 2.663319
2 Standard 2:A,1 2 2998 Ch1 265nm@4.8nm unk 0.943 315202 2.656760
3 Standard 2:A,1 3 2998 Ch1 265nm@4.8nm unk 0.942 314393 2.655629
4 Standard 2:A,1 4 2998 Ch1 265nm@4.8nm unk 0.942 314426 2.652515
5 Standard 2:A,1 5 2998 Ch1 265nm@4.8nm unk 0.942 313748 2.654692
6 Standard 2:A,1 6 2998 Ch1 265nm@4.8nm unk 0.942 312771 2.653332
7 Standard 2:A,1 7 2998 Ch1 265nm@4.8nm unk 0.941 312896 2.656655
Mean 0.942 314226.557 2.656
Std. Dev. 0.000 1213.439 0.004
% RSD 0.1 0.4 0.1